莫博赛替尼/莫博替尼仿制药是否存在？ How can patients choose more economical treatment options?

Mobocertinib , as a targeted drug targeting EGFR exon 20 insertion mutations non-small cell lung cancer (NSCLC) , has attracted much attention due to its significant efficacy. However, the high price of original drugs prohibits many patients, so the existence of generic drugs has become a common concern among patients. At present, the original drug of mobosetinib is produced by Takeda Pharmaceuticals (Takeda). Although it was once launched in China, it has been taken off the shelves, and the price and medical insurance reimbursement are not yet clear. In Hong Kong, each box of 40mg*30 tablets of the clinical version of the drug sells for about more than 7,000 yuan, but it should be noted that the price may fluctuate with the exchange rate.

At the same time, generic versions of mobotinib have appeared in overseas markets. For example, the price of a 40mg*120-tablet generic drug produced by a pharmaceutical factory in Laos may be only more than 4,000 yuan, and the price/performance ratio is significantly higher than that of the original drug. The ingredients of these generic drugs are similar to the original drugs, but the prices are more affordable, providing a new choice for patients with limited financial conditions. However, when choosing generic drugs, you need to be extra cautious to ensure that the drugs are from legitimate sources and avoid buying fake or inferior drugs.

For patients, the choice of generic or original drugs requires comprehensive consideration of efficacy, safety and economic ability. If you choose generic drugs, it is recommended to ensure the quality of the drugs through reliable overseas drug purchasing platforms or consulting professional doctors. In addition, patients can also pay attention to the charitable assistance programs or medical insurance policies of pharmaceutical companies to reduce their financial burden. In general, the generic version of mobosetinib provides patients with more choices, but doctors’ instructions must be strictly followed during use to ensure the safety and effectiveness of the treatment.

Reference materials:https://en.wikipedia.org/wiki/Mobocertinib